Idiopathic Bilateral Vestibulopathy: Peripheral Vestibular Disorders and Their Repercussions (VBI)

July 22, 2025 updated by: University Hospital, Caen

Vestibulopathie bilatérale Idiopathique : caractérisation Des Atteintes Vestibulaires périphériques et de Leurs Retentissements Posturaux, végétatifs, émotionnels et Cognitifs

The goal of this exploratory study is to gain a better understanding of the symptomatology of idiopathic bilateral vestibulopathy (IBV) by characterising as precisely as possible the type and intensity of each patient's peripheral vestibular deficit, and to investigate the link between this symptomatology and some functions influenced by the vestibular system (i.e. cognitive, emotional, vegetative functions).

Study Overview

Detailed Description

Bilateral vestibulopathy (BV) is defined as total or partial impairment of vestibular function on both sides, leading to chronic postural and visual instability. Idiopathic bilateral vestibulopathy (IBV) is a rare condition characterised by acquired BV of unknown aetiology. Although described more than thirty years ago, IBV remains a condition with imperfectly understood contours, mechanisms and consequences.

The peripheral vestibular system, located in the inner ear, is the main balance organ. Sensory information from the vestibular system is distributed to different brain structures, which perform a wide range of functions, such as maintaining stability of gaze and posture, controlling certain functions such as sleep, spatial memory and emotional processes, and perceiving movement, spatial orientation and self-image.

The most common symptoms of IBV are persistent postural instability, and, when moving the head and body, a reduction in visual acuity that can go as far as a sensation of instability of the visual environment. Patients also often report problems with orientation and spatial memory, poor body shape, sleep disorders, attentional problems, and anxiety or depression. Because little is known about this disease, diagnosis often comes late, after several years of various explorations and consultations with doctors and specialists.

Based on the observation that patients suffering from IBV have heterogeneous peripheral impairments, both qualitatively (type of sensory organ affected) and quantitatively (the impairment is more or less complete), and that the sometimes complex symptomatology is difficult to relate to the type of peripheral deficit, the aim of this project is to gain a better understanding of the symptomatology of IBV by evaluating certain functions that have recently been shown to be influenced by the vestibular system, and to relate this to the type and intensity of the peripheral deficit.

Hence, the main aim of this project is to study the link between symptomatology - both 'classic' (posturo-oculomotor) and cognitive, emotional and vegetative - and the type and intensity of vestibular disorder.

Study Type

Observational

Enrollment (Actual)

69

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Calvados
      • Caen, Calvados, France, 14000
        • UMRs 1075 COMETE Unicaen INSERM

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Participants in the patient group are member of the French Association of the Idiopathic Bilateral Vestibulopathy (AFVBI) or carry a bilateral vestibulopathy

Description

Inclusion Criteria:

  • Person over 18 years of age (male or female)
  • Healthy volunteer (for participants in the control group) or a member of the French Association of the Idiopathic Bilateral Vestibulopathy (AFVBI) or a bilateral vestibulopathy carrier (for participants in the patient group).
  • Person who has read the information sheet and given written informed consent to take part in the study.
  • Person affiliated to a social security scheme

Exclusion Criteria:

  • Declaration of illiteracy
  • Declaration of dementia (Alzheimer's disease, vascular dementia)
  • Any progressive neurological disease (brain tumour, epilepsy, migraine, stroke, sclerosis, myoclonus, chorea, neuropathy, muscular dystrophy, myotonic dystrophy, etc.)
  • All progressive psychiatric conditions (psychosis, mood or anxiety disorders, etc.),
  • Declaration of pathologies threatening short-term vital prognosis (cancer)
  • Drug addiction, alcohol dependence or coffee abuse during the last 6 months
  • Contraindications to MRI (in particular electronic or metallic implants, claustrophobia, etc.).
  • For healthy volunteers: vestibular or auditory disorders.

In addition, the vulnerable persons referred to in articles L. 1121-5 to 8 and L. 1122-1-2 of the French Public Health Code are excluded from the study:

  • Pregnant, breast-feeding or parturient women,
  • Persons deprived of their liberty, hospitalised without consent or admitted to a health or social establishment for purposes other than research,
  • Minors,
  • Adults under legal protection or unable to express their consent,
  • Persons in emergency situations who are unable to give their prior consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
IBV patients
Persons with bilateral vestibulopathy

This assessment, designed to evaluate the impact of the vestibular deficit on everyday tasks, will include questionnaires and standardised clinical tests.

The questionnaires are the Fall Efficacy Scale; the Dizziness Handicap Inventory; the Oscillopsia Severity Questionnaire; the Hospital Anxiety and Depression Scale; the Hamilton Anxiety Scale; the Global Physical Activity Questionnaire; the Motion Sickness Susceptibility Questionnaire part B; and the Cambridge Depersonalization Scale.

In addition, three standardised clinical tests will be carried out: Five Times Sit to Stand Test; Tandem walking test; and Fukuda step test (50 steps).

Five specific clinical tests will also be carried out: Sit-to-stand-with-walk-and-turn; Perception of active body rotation; Perception of walking distance; Triangle Completion Task; and Gait assessment.

Four cognitive tests from the French Focus Group on Executive Functions Assessment (GREFEX) battery will be carried out: the Stroop test; the Trail Making Test; the Baddeley's dual task; and a test of Corsi's Blocks.
This test, also known as the unilateral centrifugation test, provides a quantitative assessment of unilateral utricular otolith function, whereas the tests currently used (vestibular evoked myogenic potential, VEMP) only provide a qualitative assessment.
To assess the participants' bone mineral density, the reference technique of densitometry using two-photon absorptiometry will be used.
Participants' ability to maintain their balance will be assessed using measurements taken on the Synapsys platform. To standardise their position, they will have to stand on the platform with their feet apart, arms at their sides and look straight ahead. Volunteers will be asked to sit down between each trial. The surface area and length of the centre of pressure will be measured under open-eye balance conditions with and without image reading/exploration and dynamics. During this test, 9 balance assessment situations lasting approximately 1 minute each will be performed.

Participants will be seated on a rotating chair in the dark. Using a virtual reality headset, three visual stimuli will be presented: (A) no visual stimulus (darkness), (B) visual stimulus corresponding to a displacement of the participant along a cylindrical trajectory, (C) visual stimulus corresponding to a displacement of the participant along a conical trajectory. These 3 types of visual stimuli will be presented alone or during an Off-Vertical Axis Rotation (OVAR) with the chair axis inclined at an angle of 10° to the vertical and a rotation speed of 60°/s.

During each sequence, blood pressure, heart rate and end-tidal carbon dioxide (CO2) will be continuously recorded using standard medical equipment.

Participants will have to complete five standardised clinical questionnaires: Pittsburgh Sleep Quality Index; Spiegel questionnaire assessing sleep quality; Morningness-Eveningness questionnaire; Insomnia Severity Scale; and Epworth Sleepiness Scale.

Moreover, the activity/rest rhythm will be measured continuously by actimetry over a period of 11 days.

The volunteer will also have to wear a Somno-Art® bracelet all night long during the eleven days of monitoring to collect the volunteer's actimetry and heart rate in order to specify which sleep stage the volunteer is in and thus monitor changes in sleep stages over the course of the night.

Finally, participants will have to complete a sleep diary.

  • Classic geometric illusions (inverted T, Mueller-Lyer, Ponzo, Poggendorff, Zoellner, Hering) which generate systematic distortions will be used.
  • Time perception task: Participants will wear a virtual reality headset in which instructions will appear for 6 consecutive tasks each repeated 10 times with different durations.
  • Perception of rotation amplitude and duration: Participants will be seated on a rotating chair, in complete darkness with noise-cancelling headphones. Participant will have to estimate the duration and the amplitude of rotations of the chair.
  • Perceptual time constant: Participants will be seated on a rotating chair, in complete darkness, with a mask over their eyes and noise-cancelling headphones. After each chair rotation, participants will have to turn a crank every time the chair stops and reproduce their sensation of rotation in terms of direction (left or right) and intensity.

Participants will wear a virtual reality headset which allows them to be immersed in a virtual room similar in appearance to the one they are in. They will sit on a stool and hold a joystick in their hand. An avatar seen from behind, also sitting on a stool, will be presented in the centre of the virtual room approximately 2 m from them. The experimenter will touch several areas of the participant's back, over his clothes, with the end of the joystick. This movement will be reproduced by the virtual joystick in contact with the avatar's back, in two conditions: the synchronous condition, and the asynchronous condition.

After 2 min of stimulation, participants will perform a mental imagery task: a ball in the background of the virtual scene will roll towards them. After 3'', a black screen will appear and participants will have to imagine that the ball keeps moving towards them at the same speed. They will have to press the trigger when they think the ball has reached their level.

The imaging evaluation will include an acquisition of anatomical images of the brain in its entirety and centred on the hippocampus.; and T2*-weighted images sensitive to the blood-oxygen-level-dependent (BOLD) effect to assess functional brain activation during cognitive tasks and functional brain connectivity during rest.

For the functional activation sequences, three activation tasks will be performed, each lasting approximately 5 minutes: a mental rotation task, a time estimation task, and a prediction task.

These acquisitions will be combined with a collection of cardiorespiratory variables: respiratory movements and plethysmography. These signals will be used in the pre-processing of the functional MRI to remove physiological noise from the BOLD signal.

Controls
Healthy volunteers matched with patients with respect to their age, sex and level of education

This assessment, designed to evaluate the impact of the vestibular deficit on everyday tasks, will include questionnaires and standardised clinical tests.

The questionnaires are the Fall Efficacy Scale; the Dizziness Handicap Inventory; the Oscillopsia Severity Questionnaire; the Hospital Anxiety and Depression Scale; the Hamilton Anxiety Scale; the Global Physical Activity Questionnaire; the Motion Sickness Susceptibility Questionnaire part B; and the Cambridge Depersonalization Scale.

In addition, three standardised clinical tests will be carried out: Five Times Sit to Stand Test; Tandem walking test; and Fukuda step test (50 steps).

Five specific clinical tests will also be carried out: Sit-to-stand-with-walk-and-turn; Perception of active body rotation; Perception of walking distance; Triangle Completion Task; and Gait assessment.

This test, also known as the unilateral centrifugation test, provides a quantitative assessment of unilateral utricular otolith function, whereas the tests currently used (vestibular evoked myogenic potential, VEMP) only provide a qualitative assessment.
Participants' ability to maintain their balance will be assessed using measurements taken on the Synapsys platform. To standardise their position, they will have to stand on the platform with their feet apart, arms at their sides and look straight ahead. Volunteers will be asked to sit down between each trial. The surface area and length of the centre of pressure will be measured under open-eye balance conditions with and without image reading/exploration and dynamics. During this test, 9 balance assessment situations lasting approximately 1 minute each will be performed.
  • Classic geometric illusions (inverted T, Mueller-Lyer, Ponzo, Poggendorff, Zoellner, Hering) which generate systematic distortions will be used.
  • Time perception task: Participants will wear a virtual reality headset in which instructions will appear for 6 consecutive tasks each repeated 10 times with different durations.
  • Perception of rotation amplitude and duration: Participants will be seated on a rotating chair, in complete darkness with noise-cancelling headphones. Participant will have to estimate the duration and the amplitude of rotations of the chair.
  • Perceptual time constant: Participants will be seated on a rotating chair, in complete darkness, with a mask over their eyes and noise-cancelling headphones. After each chair rotation, participants will have to turn a crank every time the chair stops and reproduce their sensation of rotation in terms of direction (left or right) and intensity.

The imaging evaluation will include an acquisition of anatomical images of the brain in its entirety and centred on the hippocampus.; and T2*-weighted images sensitive to the blood-oxygen-level-dependent (BOLD) effect to assess functional brain activation during cognitive tasks and functional brain connectivity during rest.

For the functional activation sequences, three activation tasks will be performed, each lasting approximately 5 minutes: a mental rotation task, a time estimation task, and a prediction task.

These acquisitions will be combined with a collection of cardiorespiratory variables: respiratory movements and plethysmography. These signals will be used in the pre-processing of the functional MRI to remove physiological noise from the BOLD signal.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Center of pressure (CoP) path length
Time Frame: Posturography is assessed once, during about 30 minutes.
Stabilometric data: Total length travelled by the CoP (in mm)
Posturography is assessed once, during about 30 minutes.
Center of pressure (CoP) path amplitude
Time Frame: Posturography is assessed once, during about 30 minutes.
Stabilometric data: Maximal distance over two points of the stabilogram (in mm)
Posturography is assessed once, during about 30 minutes.
Center of pressure (CoP) surface area
Time Frame: Posturography is assessed once, during about 30 minutes.
Stabilometric data: surface travelled by the CoP (in mm²)
Posturography is assessed once, during about 30 minutes.
Ocular torsion
Time Frame: Unilateral utricular otolith function is assessed once, during about 30 minutes
During eccentric axis rotation: measure of the torsion of the eyes (in degree)
Unilateral utricular otolith function is assessed once, during about 30 minutes
Duration estimate
Time Frame: Time perception task is completed once, during about 30 minutes.
During the time perception task, subjects are asked to estimate several durations (in seconds).
Time perception task is completed once, during about 30 minutes.
Duration production
Time Frame: Time perception task is completed once, during about 30 minutes.
During the time perception task, subjects are asked to produce several durations (in seconds).
Time perception task is completed once, during about 30 minutes.
Number of correct tandem steps
Time Frame: Assessment of postural stability and active motion perception is completed once, during about 30 minutes
During tandem stance and walk, subjects are asked to stand upright in a heel-to-toe fashion with their arms crossed on their chest and walk.
Assessment of postural stability and active motion perception is completed once, during about 30 minutes
Deviation distance (Fukuda stepping test)
Time Frame: Assessment of postural stability and active motion perception is completed once, during about 30 minutes
During the Fukuda stepping test, subjects are asked to take 50 steps on the spot, on a mat, with their eyes closed and their arms outstretched in front of them. Deviation distance is measured in cm.
Assessment of postural stability and active motion perception is completed once, during about 30 minutes
Deviation angle (Fukuda stepping test)
Time Frame: Assessment of postural stability and active motion perception is completed once, during about 30 minutes
During the Fukuda stepping test, subjects are asked to take 50 steps on the spot, on a mat, with their eyes closed and their arms outstretched in front of them. Deviation angle is measured in degrees.
Assessment of postural stability and active motion perception is completed once, during about 30 minutes
Hippocampal volume
Time Frame: MRI exam is completed once, during about 1 hour
Images of hippocampus are acquired by MRI
MRI exam is completed once, during about 1 hour
Brain activation during functional tasks
Time Frame: MRI exam is completed once, during about 1 hour
Images of the brain when participants are performing cognitive tasks (mental rotation task, prediction task) are acquired by functional magnetic resonance imaging (fMRI)
MRI exam is completed once, during about 1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Center of pressure (CoP) standard deviation - Anteroposterior
Time Frame: Posturography is assessed once, during about 30 minutes.
Stabilometric data: Standard deviation of the CoP position in the anteroposterior axis (in mm)
Posturography is assessed once, during about 30 minutes.
Center of pressure (CoP) standard deviation - Mediolateral
Time Frame: Posturography is assessed once, during about 30 minutes.
Stabilometric data: Standard deviation of the CoP position in the mediolateral axis (in mm)
Posturography is assessed once, during about 30 minutes.
Duration of the word reading in the congruent condition
Time Frame: Cognitive functions are assessed once, during about 30 minutes
Stroop color and word test : time spent to read the words in the congruent condition (in seconds)
Cognitive functions are assessed once, during about 30 minutes
Duration of the colour naming
Time Frame: Cognitive functions are assessed once, during about 30 minutes
Stroop color and word test : time spent to name the colours (in seconds)
Cognitive functions are assessed once, during about 30 minutes
Duration of the word reading in the incongruent condition
Time Frame: Cognitive functions are assessed once, during about 30 minutes
Stroop color and word test : time spent to read the words in the incongruent condition (in seconds)
Cognitive functions are assessed once, during about 30 minutes
Trail making test part A
Time Frame: Cognitive functions are assessed once, during about 30 minutes
Paper and pencil Trail Making Test: Time spent by the subject to draw a line between numbers from 1 to 25 (in seconds)
Cognitive functions are assessed once, during about 30 minutes
Trail making test part B
Time Frame: Cognitive functions are assessed once, during about 30 minutes
Paper and pencil Trail Making Test: Time spent by the subject to draw a line between numbers and letters (1-A, 2-B, etc.) (in seconds)
Cognitive functions are assessed once, during about 30 minutes
Digit span during dual-task
Time Frame: Cognitive functions are assessed once, during about 30 minutes
Number of digits correctly recalled during the Baddeley's dual-task
Cognitive functions are assessed once, during about 30 minutes
Number of sequences correctly recalled
Time Frame: Cognitive functions are assessed once, during about 30 minutes
In the simple and dual conditions of the Baddeley's dual-task
Cognitive functions are assessed once, during about 30 minutes
Spatial span
Time Frame: Cognitive functions are assessed once, during about 30 minutes
Number of blocks correctly recalled during the Corsi task
Cognitive functions are assessed once, during about 30 minutes
Estimation of the duration of rotation
Time Frame: Perception of the amplitude and duration of rotations task is completed once, during about 30 minutes.
During the Perception of the amplitude and duration of rotations task, subjects seated in a rotating chair are asked to estimate the duration of the rotations (in seconds)
Perception of the amplitude and duration of rotations task is completed once, during about 30 minutes.
Estimation of the amplitude of rotation
Time Frame: Perception of the amplitude and duration of rotations task is completed once, during about 30 minutes.
During the Perception of the amplitude and duration of rotations task, subjects seated in a rotating chair are asked to estimate the amplitude of the rotations (in degree)
Perception of the amplitude and duration of rotations task is completed once, during about 30 minutes.
Deviation distance (Triangle completion task)
Time Frame: Assessment of postural stability and active motion perception is completed once, during about 30 minutes
During the triangle completion task, the participant will wear a blindfold and a noise-cancelling headphones. Guided by the experimenter, who will hold them by the shoulders, they will walk along the first two sides of a triangle. The participant will then have to turn on their own and walk along the third side to get back to the starting point. The deviation distance is measured in cm.
Assessment of postural stability and active motion perception is completed once, during about 30 minutes
Deviation angle (Triangle completion task)
Time Frame: Assessment of postural stability and active motion perception is completed once, during about 30 minutes
During the triangle completion task, the participant will wear a blindfold and a noise-cancelling headphones. Guided by the experimenter, who will hold them by the shoulders, they will walk along the first two sides of a triangle. The participant will then have to turn on their own and walk along the third side to get back to the starting point. The deviation angle is measured in degree.
Assessment of postural stability and active motion perception is completed once, during about 30 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pierre DENISE, MD-PhD, UMRs 1075 COMETE Unicaen / INSERM

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 5, 2022

Primary Completion (Actual)

December 15, 2023

Study Completion (Actual)

December 31, 2024

Study Registration Dates

First Submitted

May 22, 2024

First Submitted That Met QC Criteria

June 25, 2024

First Posted (Actual)

June 26, 2024

Study Record Updates

Last Update Posted (Actual)

July 25, 2025

Last Update Submitted That Met QC Criteria

July 22, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Idiopathic Bilateral Vestibulopathy

Clinical Trials on Assessment of postural stability and active motion perception

Subscribe